Rank | Gene Set | Z-score |
---|---|---|
1 | response to interleukin-15 (GO:0070672) | 7.08507369 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.70434606 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.57314156 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.57314156 |
5 | negative T cell selection (GO:0043383) | 6.34368943 |
6 | cellular response to interleukin-15 (GO:0071350) | 6.26072391 |
7 | interferon-gamma production (GO:0032609) | 6.11828602 |
8 | negative thymic T cell selection (GO:0045060) | 6.07331379 |
9 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.85106015 |
10 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.82168887 |
11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.71998021 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.54781451 |
13 | tolerance induction (GO:0002507) | 5.52009178 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.15408640 |
15 | thymic T cell selection (GO:0045061) | 5.11577135 |
16 | regulation of gamma-delta T cell activation (GO:0046643) | 5.10658112 |
17 | positive thymic T cell selection (GO:0045059) | 5.09115917 |
18 | activated T cell proliferation (GO:0050798) | 4.97200578 |
19 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.88072575 |
20 | tyrosine phosphorylation of STAT protein (GO:0007260) | 4.87235035 |
21 | T cell selection (GO:0045058) | 4.84144197 |
22 | positive T cell selection (GO:0043368) | 4.78452833 |
23 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.73918734 |
24 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.73918734 |
25 | T cell migration (GO:0072678) | 4.62925065 |
26 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.62783950 |
27 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.62783950 |
28 | T cell costimulation (GO:0031295) | 4.43263087 |
29 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.40813126 |
30 | negative regulation of cell killing (GO:0031342) | 4.39036830 |
31 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.39036830 |
32 | lymphocyte costimulation (GO:0031294) | 4.37590954 |
33 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.36166833 |
34 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.33969400 |
35 | positive regulation of isotype switching (GO:0045830) | 4.33747399 |
36 | T cell receptor signaling pathway (GO:0050852) | 4.33156786 |
37 | leukocyte aggregation (GO:0070486) | 4.30221224 |
38 | positive regulation of interleukin-2 production (GO:0032743) | 4.13995431 |
39 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.96670871 |
40 | DNA deamination (GO:0045006) | 3.95580677 |
41 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.91090047 |
42 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.86255328 |
43 | positive regulation of B cell mediated immunity (GO:0002714) | 3.83108724 |
44 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.83108724 |
45 | regulation of regulatory T cell differentiation (GO:0045589) | 3.73581724 |
46 | positive regulation of humoral immune response (GO:0002922) | 3.69764099 |
47 | positive regulation of interleukin-17 production (GO:0032740) | 3.69571988 |
48 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.68773172 |
49 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.65037202 |
50 | T cell homeostasis (GO:0043029) | 3.64377301 |
51 | positive regulation of DNA recombination (GO:0045911) | 3.62092945 |
52 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.61589862 |
53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.60912457 |
54 | positive regulation of immunoglobulin production (GO:0002639) | 3.59789905 |
55 | cytidine deamination (GO:0009972) | 3.59007898 |
56 | cytidine metabolic process (GO:0046087) | 3.59007898 |
57 | cytidine catabolic process (GO:0006216) | 3.59007898 |
58 | * regulation of T cell mediated cytotoxicity (GO:0001914) | 3.56390889 |
59 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.55279232 |
60 | regulation of isotype switching (GO:0045191) | 3.54738879 |
61 | * positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.52564014 |
62 | natural killer cell activation (GO:0030101) | 3.49179621 |
63 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.46102962 |
64 | regulation of interleukin-2 production (GO:0032663) | 3.44641218 |
65 | regulation of T cell tolerance induction (GO:0002664) | 3.42099319 |
66 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.41724493 |
67 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.41525650 |
68 | regulation of response to interferon-gamma (GO:0060330) | 3.36523414 |
69 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.35358904 |
70 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.33664957 |
71 | * positive regulation of cell killing (GO:0031343) | 3.33049982 |
72 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.32762931 |
73 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.31399119 |
74 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 3.30951136 |
75 | * regulation of cell killing (GO:0031341) | 3.29074662 |
76 | alpha-beta T cell activation (GO:0046631) | 3.26888854 |
77 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.25790867 |
78 | regulation of B cell mediated immunity (GO:0002712) | 3.25644242 |
79 | alpha-beta T cell differentiation (GO:0046632) | 3.25520461 |
80 | regulation of immunoglobulin production (GO:0002637) | 3.24551491 |
81 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.22661430 |
82 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.21149147 |
83 | response to protozoan (GO:0001562) | 3.20413711 |
84 | T cell proliferation (GO:0042098) | 3.20068202 |
85 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.19861942 |
86 | T cell differentiation involved in immune response (GO:0002292) | 3.19426981 |
87 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.19426981 |
88 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.19426981 |
89 | negative regulation of interleukin-12 production (GO:0032695) | 3.18155337 |
90 | regulation of B cell differentiation (GO:0045577) | 3.17745291 |
91 | mast cell activation (GO:0045576) | 3.16843582 |
92 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.15270828 |
93 | Peyers patch development (GO:0048541) | 3.14937442 |
94 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.14937442 |
95 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 3.14932613 |
96 | NIK/NF-kappaB signaling (GO:0038061) | 3.13828697 |
97 | positive regulation of macrophage differentiation (GO:0045651) | 3.10771618 |
98 | T cell differentiation (GO:0030217) | 3.09595928 |
99 | cellular extravasation (GO:0045123) | 3.09487146 |
100 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.08990231 |
101 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.08990231 |
102 | immunoglobulin mediated immune response (GO:0016064) | 3.08413654 |
103 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06002174 |
104 | regulation of natural killer cell differentiation (GO:0032823) | 3.05502202 |
105 | defense response to protozoan (GO:0042832) | 3.05460786 |
106 | positive regulation by symbiont of host defense response (GO:0052509) | 3.03975367 |
107 | modulation by symbiont of host defense response (GO:0052031) | 3.03975367 |
108 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.03975367 |
109 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.03975367 |
110 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.03975367 |
111 | modulation by symbiont of host immune response (GO:0052553) | 3.03975367 |
112 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.03781648 |
113 | * regulation of lymphocyte mediated immunity (GO:0002706) | 3.03719156 |
114 | response to type I interferon (GO:0034340) | 3.03580434 |
115 | B cell receptor signaling pathway (GO:0050853) | 3.03015422 |
116 | positive regulation of T cell cytokine production (GO:0002726) | 3.02116768 |
117 | type I interferon signaling pathway (GO:0060337) | 2.99737141 |
118 | cellular response to type I interferon (GO:0071357) | 2.99737141 |
119 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.99653252 |
120 | neutrophil activation (GO:0042119) | 2.99331249 |
121 | lymphocyte homeostasis (GO:0002260) | 2.98489085 |
122 | fucose catabolic process (GO:0019317) | 2.98387675 |
123 | L-fucose metabolic process (GO:0042354) | 2.98387675 |
124 | L-fucose catabolic process (GO:0042355) | 2.98387675 |
125 | negative regulation of T cell mediated immunity (GO:0002710) | 2.98356447 |
126 | cellular response to interleukin-4 (GO:0071353) | 2.98296888 |
127 | myeloid dendritic cell activation (GO:0001773) | 2.97486498 |
128 | myeloid dendritic cell differentiation (GO:0043011) | 2.97060631 |
129 | * positive regulation of defense response to virus by host (GO:0002230) | 2.96936003 |
130 | positive regulation of B cell differentiation (GO:0045579) | 2.95771068 |
131 | mast cell activation involved in immune response (GO:0002279) | 2.95714047 |
132 | mast cell degranulation (GO:0043303) | 2.95714047 |
133 | positive regulation of granulocyte differentiation (GO:0030854) | 2.95108661 |
134 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.93233116 |
135 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.91292867 |
136 | neutrophil activation involved in immune response (GO:0002283) | 2.90791013 |
137 | detection of bacterium (GO:0016045) | 2.90112400 |
138 | negative regulation of interleukin-1 production (GO:0032692) | 2.89316339 |
139 | detection of other organism (GO:0098543) | 2.85774889 |
140 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84453599 |
141 | leukocyte degranulation (GO:0043299) | 2.83078800 |
142 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.81989835 |
143 | regulation of antigen processing and presentation (GO:0002577) | 2.80323188 |
144 | negative regulation of innate immune response (GO:0045824) | 2.78993657 |
145 | macrophage activation involved in immune response (GO:0002281) | 2.77213567 |
146 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.76271587 |
147 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.76197236 |
148 | regulation of tolerance induction (GO:0002643) | 2.74703331 |
149 | behavioral response to nicotine (GO:0035095) | 2.73922264 |
150 | myeloid cell activation involved in immune response (GO:0002275) | 2.72936219 |
151 | regulation of mast cell activation (GO:0033003) | 2.70624948 |
152 | * regulation of T cell mediated immunity (GO:0002709) | 2.68328793 |
153 | dendritic cell chemotaxis (GO:0002407) | 2.67656825 |
154 | granulocyte activation (GO:0036230) | 2.66984925 |
155 | microglial cell activation (GO:0001774) | 2.66226030 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.06326211 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.98538098 |
3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.32186225 |
4 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.75783638 |
5 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.56454959 |
6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.51755328 |
7 | MYC_22102868_ChIP-Seq_BL_Human | 3.39201206 |
8 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.37458356 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.34308189 |
10 | * MYB_26560356_Chip-Seq_TH2_Human | 3.09297834 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.03867224 |
12 | MAF_26560356_Chip-Seq_TH1_Human | 2.92116704 |
13 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.90978173 |
14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.81982425 |
15 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.81242676 |
16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.66247769 |
17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.65213210 |
18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.61802779 |
19 | * MYB_26560356_Chip-Seq_TH1_Human | 2.55418226 |
20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.49489631 |
21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.42217032 |
22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.34341947 |
23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.24647002 |
24 | MAF_26560356_Chip-Seq_TH2_Human | 2.21071574 |
25 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05853041 |
26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98155852 |
27 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94288728 |
28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.93823599 |
29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91834566 |
30 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.90014698 |
31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.88922071 |
32 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88291742 |
33 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.87072804 |
34 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.83561499 |
35 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.82313812 |
36 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80647493 |
37 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.76171476 |
38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75546391 |
39 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75055183 |
40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72485281 |
41 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66008928 |
42 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.65601345 |
43 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.64682592 |
44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57595701 |
45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57163429 |
46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.53935362 |
47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.53388181 |
48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53335137 |
49 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.53223128 |
50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.51228610 |
51 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50104098 |
52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.49775305 |
53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.48886415 |
54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45979625 |
55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.44857658 |
56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36588649 |
57 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36145725 |
58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34977300 |
59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33994068 |
60 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29477830 |
61 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.27750837 |
62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27745807 |
63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.25526063 |
64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22465134 |
65 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21684886 |
66 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.20781836 |
67 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20638371 |
68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20388873 |
69 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19927714 |
70 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.19585356 |
71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19350193 |
72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.18298469 |
73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.18081878 |
74 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.18004927 |
75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17597619 |
76 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.17562358 |
77 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17232864 |
78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.16701727 |
79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14968874 |
80 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.14208777 |
81 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.12729209 |
82 | GATA3_26560356_Chip-Seq_TH2_Human | 1.12142039 |
83 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.11075299 |
84 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 1.10340743 |
85 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09742203 |
86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.09237070 |
87 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08630267 |
88 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08287163 |
89 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07652757 |
90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06841501 |
91 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06679192 |
92 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.05903589 |
93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04578400 |
94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04571725 |
95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03212458 |
96 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02787888 |
97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.02668958 |
98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02587873 |
99 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.02200903 |
100 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.02200903 |
101 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.01957305 |
102 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.01311179 |
103 | GATA3_26560356_Chip-Seq_TH1_Human | 1.01303601 |
104 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.00757644 |
105 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.00254175 |
106 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.99514580 |
107 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98870203 |
108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98427993 |
109 | P300_27268052_Chip-Seq_Bcells_Human | 0.98349519 |
110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98312639 |
111 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.98211851 |
112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97884210 |
113 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.96941444 |
114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96087994 |
115 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.95461685 |
116 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95224205 |
117 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94926588 |
118 | * ERA_21632823_ChIP-Seq_H3396_Human | 0.94649489 |
119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.94243763 |
120 | GATA1_22025678_ChIP-Seq_K562_Human | 0.93910614 |
121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.90051413 |
122 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.89601174 |
123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89122140 |
124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.88902708 |
125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87307845 |
126 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.87038962 |
127 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87022347 |
128 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86408461 |
129 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.86373315 |
130 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.85750861 |
131 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84738202 |
132 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84082498 |
133 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.84071294 |
134 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.84071294 |
135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83516043 |
136 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.82517186 |
137 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82259686 |
138 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82216057 |
139 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82059475 |
140 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81435056 |
141 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.80631368 |
142 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79473069 |
143 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78892941 |
144 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.76968229 |
145 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.76927947 |
146 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76842689 |
147 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.76673666 |
148 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.76280585 |
149 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.74565165 |
150 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74224585 |
151 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.73818887 |
152 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73479462 |
153 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.73007407 |
154 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.71988361 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005671_abnormal_response_to | 4.85007179 |
2 | MP0003763_abnormal_thymus_physiology | 4.47520121 |
3 | MP0000685_abnormal_immune_system | 3.56889150 |
4 | MP0001790_abnormal_immune_system | 3.43135192 |
5 | MP0005387_immune_system_phenotype | 3.43135192 |
6 | MP0001835_abnormal_antigen_presentation | 3.41887462 |
7 | MP0001800_abnormal_humoral_immune | 3.27623902 |
8 | MP0009333_abnormal_splenocyte_physiolog | 3.17175686 |
9 | MP0005000_abnormal_immune_tolerance | 2.94148827 |
10 | MP0009785_altered_susceptibility_to | 2.91761389 |
11 | MP0001873_stomach_inflammation | 2.79510481 |
12 | * MP0002723_abnormal_immune_serum | 2.77502321 |
13 | MP0006082_CNS_inflammation | 2.76728484 |
14 | MP0003436_decreased_susceptibility_to | 2.72360214 |
15 | MP0002396_abnormal_hematopoietic_system | 2.70369673 |
16 | MP0002398_abnormal_bone_marrow | 2.68129707 |
17 | * MP0002420_abnormal_adaptive_immunity | 2.65478234 |
18 | MP0003866_abnormal_defecation | 2.63460220 |
19 | * MP0001819_abnormal_immune_cell | 2.60503790 |
20 | MP0003300_gastrointestinal_ulcer | 2.57834503 |
21 | MP0002166_altered_tumor_susceptibility | 2.55521850 |
22 | MP0002452_abnormal_antigen_presenting | 2.55210287 |
23 | MP0002405_respiratory_system_inflammati | 2.48852190 |
24 | MP0005025_abnormal_response_to | 2.48630913 |
25 | MP0010155_abnormal_intestine_physiology | 2.48449516 |
26 | MP0000703_abnormal_thymus_morphology | 2.47490821 |
27 | * MP0000716_abnormal_immune_system | 2.32089733 |
28 | MP0002006_tumorigenesis | 2.23685253 |
29 | MP0002722_abnormal_immune_system | 2.22512203 |
30 | MP0002933_joint_inflammation | 2.20329684 |
31 | MP0000689_abnormal_spleen_morphology | 2.14537425 |
32 | MP0001986_abnormal_taste_sensitivity | 2.13672146 |
33 | MP0004510_myositis | 1.93409192 |
34 | * MP0002429_abnormal_blood_cell | 1.92768267 |
35 | MP0003724_increased_susceptibility_to | 1.89274776 |
36 | MP0004947_skin_inflammation | 1.86196308 |
37 | MP0002148_abnormal_hypersensitivity_rea | 1.82786416 |
38 | MP0002277_abnormal_respiratory_mucosa | 1.79055086 |
39 | MP0002419_abnormal_innate_immunity | 1.74200713 |
40 | MP0001845_abnormal_inflammatory_respons | 1.70626744 |
41 | MP0003303_peritoneal_inflammation | 1.69703508 |
42 | MP0000569_abnormal_digit_pigmentation | 1.65765665 |
43 | MP0003448_altered_tumor_morphology | 1.60403598 |
44 | MP0005310_abnormal_salivary_gland | 1.59645887 |
45 | MP0001853_heart_inflammation | 1.53804039 |
46 | MP0004808_abnormal_hematopoietic_stem | 1.52685969 |
47 | MP0004381_abnormal_hair_follicle | 1.52360317 |
48 | MP0005464_abnormal_platelet_physiology | 1.51507356 |
49 | MP0002138_abnormal_hepatobiliary_system | 1.43845778 |
50 | MP0000465_gastrointestinal_hemorrhage | 1.39111209 |
51 | MP0008057_abnormal_DNA_replication | 1.32506656 |
52 | MP0003195_calcinosis | 1.26162797 |
53 | MP0000490_abnormal_crypts_of | 1.24780171 |
54 | MP0001851_eye_inflammation | 1.24686150 |
55 | MP0003646_muscle_fatigue | 1.23327057 |
56 | MP0001501_abnormal_sleep_pattern | 1.19391724 |
57 | MP0001968_abnormal_touch/_nociception | 1.16783155 |
58 | MP0001533_abnormal_skeleton_physiology | 1.15750084 |
59 | MP0000858_altered_metastatic_potential | 1.15056748 |
60 | * MP0008469_abnormal_protein_level | 1.14870063 |
61 | MP0010307_abnormal_tumor_latency | 1.13963030 |
62 | MP0008877_abnormal_DNA_methylation | 1.11963663 |
63 | MP0003183_abnormal_peptide_metabolism | 1.11856972 |
64 | MP0002019_abnormal_tumor_incidence | 1.10088159 |
65 | MP0002876_abnormal_thyroid_physiology | 1.10072344 |
66 | MP0010352_gastrointestinal_tract_polyps | 1.08986544 |
67 | MP0001545_abnormal_hematopoietic_system | 1.06819705 |
68 | MP0005397_hematopoietic_system_phenotyp | 1.06819705 |
69 | MP0008872_abnormal_physiological_respon | 1.05054164 |
70 | MP0002254_reproductive_system_inflammat | 1.01519130 |
71 | MP0000372_irregular_coat_pigmentation | 1.01250667 |
72 | MP0010094_abnormal_chromosome_stability | 0.99750482 |
73 | MP0005551_abnormal_eye_electrophysiolog | 0.98501243 |
74 | MP0005645_abnormal_hypothalamus_physiol | 0.98276451 |
75 | MP0003787_abnormal_imprinting | 0.97972660 |
76 | MP0002102_abnormal_ear_morphology | 0.96845630 |
77 | MP0004142_abnormal_muscle_tone | 0.93842934 |
78 | MP0002693_abnormal_pancreas_physiology | 0.93224190 |
79 | MP0001881_abnormal_mammary_gland | 0.93083821 |
80 | MP0003077_abnormal_cell_cycle | 0.92461097 |
81 | MP0000015_abnormal_ear_pigmentation | 0.89671260 |
82 | MP0003172_abnormal_lysosome_physiology | 0.88029920 |
83 | MP0004043_abnormal_pH_regulation | 0.87358933 |
84 | MP0002928_abnormal_bile_duct | 0.84381339 |
85 | MP0005075_abnormal_melanosome_morpholog | 0.83822931 |
86 | MP0001348_abnormal_lacrimal_gland | 0.82473337 |
87 | MP0005167_abnormal_blood-brain_barrier | 0.81661586 |
88 | MP0008875_abnormal_xenobiotic_pharmacok | 0.81509819 |
89 | MP0000920_abnormal_myelination | 0.80770409 |
90 | MP0003011_delayed_dark_adaptation | 0.79958126 |
91 | MP0009278_abnormal_bone_marrow | 0.79855350 |
92 | MP0003693_abnormal_embryo_hatching | 0.78063307 |
93 | MP0002998_abnormal_bone_remodeling | 0.76944766 |
94 | MP0009765_abnormal_xenobiotic_induced | 0.76583974 |
95 | MP0009763_increased_sensitivity_to | 0.76379021 |
96 | MP0001919_abnormal_reproductive_system | 0.75577956 |
97 | MP0004130_abnormal_muscle_cell | 0.74079199 |
98 | MP0005076_abnormal_cell_differentiation | 0.73965688 |
99 | MP0005451_abnormal_body_composition | 0.73300072 |
100 | MP0004742_abnormal_vestibular_system | 0.72753435 |
101 | MP0005377_hearing/vestibular/ear_phenot | 0.72642663 |
102 | MP0003878_abnormal_ear_physiology | 0.72642663 |
103 | MP0005023_abnormal_wound_healing | 0.71153440 |
104 | MP0005084_abnormal_gallbladder_morpholo | 0.71024827 |
105 | MP0003111_abnormal_nucleus_morphology | 0.69618705 |
106 | MP0000477_abnormal_intestine_morphology | 0.69436311 |
107 | MP0000604_amyloidosis | 0.69331002 |
108 | MP0004957_abnormal_blastocyst_morpholog | 0.68281534 |
109 | MP0003806_abnormal_nucleotide_metabolis | 0.66193761 |
110 | MP0002132_abnormal_respiratory_system | 0.65782492 |
111 | MP0001663_abnormal_digestive_system | 0.64775899 |
112 | MP0002653_abnormal_ependyma_morphology | 0.64648228 |
113 | MP0004883_abnormal_blood_vessel | 0.64588232 |
114 | MP0003252_abnormal_bile_duct | 0.63677894 |
115 | MP0000427_abnormal_hair_cycle | 0.63373215 |
116 | MP0003045_fibrosis | 0.61058575 |
117 | MP0001765_abnormal_ion_homeostasis | 0.60252911 |
118 | MP0002095_abnormal_skin_pigmentation | 0.59943912 |
119 | MP0009745_abnormal_behavioral_response | 0.59710935 |
120 | MP0002736_abnormal_nociception_after | 0.59351701 |
121 | MP0000609_abnormal_liver_physiology | 0.59271822 |
122 | MP0008873_increased_physiological_sensi | 0.59235060 |
123 | MP0000470_abnormal_stomach_morphology | 0.58069675 |
124 | MP0003091_abnormal_cell_migration | 0.57926046 |
125 | MP0005166_decreased_susceptibility_to | 0.57379548 |
126 | MP0005253_abnormal_eye_physiology | 0.57300720 |
127 | MP0000313_abnormal_cell_death | 0.56965594 |
128 | MP0009764_decreased_sensitivity_to | 0.56844026 |
129 | MP0000230_abnormal_systemic_arterial | 0.56335128 |
130 | MP0002163_abnormal_gland_morphology | 0.55960140 |
131 | MP0000350_abnormal_cell_proliferation | 0.55557407 |
132 | MP0000627_abnormal_mammary_gland | 0.53693286 |
133 | MP0003453_abnormal_keratinocyte_physiol | 0.52763066 |
134 | MP0008961_abnormal_basal_metabolism | 0.51582000 |
135 | MP0008007_abnormal_cellular_replicative | 0.51128217 |
136 | MP0001730_embryonic_growth_arrest | 0.50146568 |
137 | MP0001727_abnormal_embryo_implantation | 0.48660942 |
138 | MP0001216_abnormal_epidermal_layer | 0.45930298 |
139 | MP0003795_abnormal_bone_structure | 0.44008250 |
140 | MP0002009_preneoplasia | 0.42419682 |
141 | MP0008770_decreased_survivor_rate | 0.39638599 |
142 | MP0001191_abnormal_skin_condition | 0.39618117 |
143 | MP0000598_abnormal_liver_morphology | 0.39383315 |
144 | MP0005174_abnormal_tail_pigmentation | 0.37438162 |
145 | MP0002083_premature_death | 0.37121999 |
146 | MP0000733_abnormal_muscle_development | 0.35959696 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 6.83229175 |
2 | Abnormality of T cell number (HP:0011839) | 6.48180887 |
3 | Abnormality of T cells (HP:0002843) | 5.19759169 |
4 | Chronic otitis media (HP:0000389) | 5.16819263 |
5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.15098638 |
6 | Myositis (HP:0100614) | 5.04876202 |
7 | Panhypogammaglobulinemia (HP:0003139) | 4.90427218 |
8 | Nasal polyposis (HP:0100582) | 4.88421404 |
9 | IgM deficiency (HP:0002850) | 4.88255825 |
10 | Recurrent bronchitis (HP:0002837) | 4.87862516 |
11 | Recurrent fungal infections (HP:0002841) | 4.79477343 |
12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.65795083 |
13 | Recurrent viral infections (HP:0004429) | 4.57186611 |
14 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.46351726 |
15 | Recurrent cutaneous fungal infections (HP:0011370) | 4.46351726 |
16 | Chronic diarrhea (HP:0002028) | 4.40375963 |
17 | Severe combined immunodeficiency (HP:0004430) | 4.30037622 |
18 | Optic neuritis (HP:0100653) | 4.24633840 |
19 | Retrobulbar optic neuritis (HP:0100654) | 4.24633840 |
20 | Stomatitis (HP:0010280) | 4.11349661 |
21 | Abnormality of the nasal mucosa (HP:0000433) | 4.00376027 |
22 | Abnormality of T cell physiology (HP:0011840) | 3.93260720 |
23 | Combined immunodeficiency (HP:0005387) | 3.91777297 |
24 | Orchitis (HP:0100796) | 3.78751328 |
25 | Abnormality of B cell number (HP:0010975) | 3.72065495 |
26 | B lymphocytopenia (HP:0010976) | 3.72065495 |
27 | Eczematoid dermatitis (HP:0000976) | 3.57986387 |
28 | IgG deficiency (HP:0004315) | 3.54015456 |
29 | IgA deficiency (HP:0002720) | 3.52616862 |
30 | Inflammation of the large intestine (HP:0002037) | 3.52111790 |
31 | Gastrointestinal inflammation (HP:0004386) | 3.43577163 |
32 | Joint swelling (HP:0001386) | 3.42534029 |
33 | Congenital stationary night blindness (HP:0007642) | 3.39455522 |
34 | Vasculitis (HP:0002633) | 3.35648807 |
35 | Meningitis (HP:0001287) | 3.26487563 |
36 | Recurrent bacterial skin infections (HP:0005406) | 3.24909516 |
37 | Encephalitis (HP:0002383) | 3.21937271 |
38 | Pustule (HP:0200039) | 3.18347018 |
39 | Hemoptysis (HP:0002105) | 3.13711501 |
40 | Pulmonary infiltrates (HP:0002113) | 3.12596329 |
41 | Stomach cancer (HP:0012126) | 3.12269104 |
42 | Abnormality of eosinophils (HP:0001879) | 3.09326782 |
43 | Increased density of long bones (HP:0006392) | 3.06394053 |
44 | Lymphopenia (HP:0001888) | 3.01567155 |
45 | Abnormality of the fingertips (HP:0001211) | 2.96363280 |
46 | Lymphoma (HP:0002665) | 2.96248884 |
47 | Eosinophilia (HP:0001880) | 2.91494796 |
48 | Keratoconjunctivitis sicca (HP:0001097) | 2.90081196 |
49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.89550373 |
50 | Thrombocytosis (HP:0001894) | 2.88061556 |
51 | Leukocytosis (HP:0001974) | 2.87944222 |
52 | Recurrent skin infections (HP:0001581) | 2.86845600 |
53 | Increased IgE level (HP:0003212) | 2.82256924 |
54 | Autoimmune hemolytic anemia (HP:0001890) | 2.76618342 |
55 | Spontaneous hematomas (HP:0007420) | 2.74593012 |
56 | Keratoconjunctivitis (HP:0001096) | 2.73805848 |
57 | Arterial thrombosis (HP:0004420) | 2.73697409 |
58 | Granulocytopenia (HP:0001913) | 2.72811542 |
59 | Gastrointestinal infarctions (HP:0005244) | 2.67393833 |
60 | Gastrointestinal stroma tumor (HP:0100723) | 2.65088440 |
61 | Gingival bleeding (HP:0000225) | 2.63600236 |
62 | Pancreatic cysts (HP:0001737) | 2.63367018 |
63 | Attenuation of retinal blood vessels (HP:0007843) | 2.61897984 |
64 | Bronchitis (HP:0012387) | 2.61804236 |
65 | Hypochromic anemia (HP:0001931) | 2.60908653 |
66 | Pulmonary embolism (HP:0002204) | 2.60085559 |
67 | Thyroiditis (HP:0100646) | 2.58024912 |
68 | Cheilitis (HP:0100825) | 2.53688445 |
69 | Hypergammaglobulinemia (HP:0010702) | 2.46855908 |
70 | Recurrent sinusitis (HP:0011108) | 2.44879620 |
71 | Gangrene (HP:0100758) | 2.44235726 |
72 | Increased IgM level (HP:0003496) | 2.40321755 |
73 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.39988208 |
74 | Molar tooth sign on MRI (HP:0002419) | 2.39369751 |
75 | Abnormality of midbrain morphology (HP:0002418) | 2.39369751 |
76 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36139683 |
77 | Obstructive lung disease (HP:0006536) | 2.36139683 |
78 | Persistence of primary teeth (HP:0006335) | 2.34250654 |
79 | Chest pain (HP:0100749) | 2.32856474 |
80 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.30521341 |
81 | Abnormal drinking behavior (HP:0030082) | 2.28776132 |
82 | Polydipsia (HP:0001959) | 2.28776132 |
83 | Abnormal platelet volume (HP:0011876) | 2.28527966 |
84 | Chronic sinusitis (HP:0011109) | 2.26945410 |
85 | Emphysema (HP:0002097) | 2.26480705 |
86 | Mediastinal lymphadenopathy (HP:0100721) | 2.25088675 |
87 | Hypochromic microcytic anemia (HP:0004840) | 2.22206239 |
88 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.20826833 |
89 | Basal cell carcinoma (HP:0002671) | 2.18835916 |
90 | Abolished electroretinogram (ERG) (HP:0000550) | 2.18043334 |
91 | Autoimmune thrombocytopenia (HP:0001973) | 2.17445921 |
92 | Epistaxis (HP:0000421) | 2.17042501 |
93 | Abnormality of the renal cortex (HP:0011035) | 2.16000449 |
94 | Petechiae (HP:0000967) | 2.15398382 |
95 | Abnormality of macrophages (HP:0004311) | 2.13968461 |
96 | Arthralgia (HP:0002829) | 2.11100656 |
97 | Recurrent abscess formation (HP:0002722) | 2.09636489 |
98 | Interstitial pulmonary disease (HP:0006530) | 2.07569575 |
99 | Abnormality of the pleura (HP:0002103) | 2.05832789 |
100 | Pancreatic fibrosis (HP:0100732) | 2.05616874 |
101 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04882694 |
102 | Anorexia (HP:0002039) | 1.97075969 |
103 | Amaurosis fugax (HP:0100576) | 1.94874720 |
104 | Keratitis (HP:0000491) | 1.93493294 |
105 | Leukopenia (HP:0001882) | 1.91358687 |
106 | Episodic fever (HP:0001954) | 1.89930001 |
107 | True hermaphroditism (HP:0010459) | 1.87875586 |
108 | Papilloma (HP:0012740) | 1.85418448 |
109 | Verrucae (HP:0200043) | 1.85418448 |
110 | Progressive inability to walk (HP:0002505) | 1.85393224 |
111 | Skin ulcer (HP:0200042) | 1.84659878 |
112 | Chronic hepatic failure (HP:0100626) | 1.83447470 |
113 | Urticaria (HP:0001025) | 1.83060893 |
114 | Type II lissencephaly (HP:0007260) | 1.81678646 |
115 | Prolonged bleeding time (HP:0003010) | 1.81009644 |
116 | Agammaglobulinemia (HP:0004432) | 1.80885785 |
117 | Abnormality of the prostate (HP:0008775) | 1.79332288 |
118 | Increased mean platelet volume (HP:0011877) | 1.78490277 |
119 | Hepatosplenomegaly (HP:0001433) | 1.78016108 |
120 | Colitis (HP:0002583) | 1.77811789 |
121 | Abnormality of the endocardium (HP:0004306) | 1.77754805 |
122 | Cellulitis (HP:0100658) | 1.75656559 |
123 | Hemiplegia (HP:0002301) | 1.75102195 |
124 | Polyuria (HP:0000103) | 1.74742205 |
125 | Nephronophthisis (HP:0000090) | 1.72614634 |
126 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.72184381 |
127 | Bronchiectasis (HP:0002110) | 1.72025690 |
128 | Hypoproteinemia (HP:0003075) | 1.71958091 |
129 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71696749 |
130 | Neutropenia (HP:0001875) | 1.71666053 |
131 | Hyperventilation (HP:0002883) | 1.71413153 |
132 | Decreased circulating renin level (HP:0003351) | 1.70958052 |
133 | Congenital sensorineural hearing impairment (HP:0008527) | 1.70902736 |
134 | Increased serum ferritin (HP:0003281) | 1.70853812 |
135 | Acute myeloid leukemia (HP:0004808) | 1.70545226 |
136 | Polyneuropathy (HP:0001271) | 1.70365722 |
137 | Clumsiness (HP:0002312) | 1.69443841 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 5.75207207 |
2 | TXK | 5.62365696 |
3 | JAK3 | 3.91991591 |
4 | FRK | 3.22893743 |
5 | EEF2K | 3.07418086 |
6 | ITK | 2.93819118 |
7 | ZAP70 | 2.67926808 |
8 | FGFR4 | 2.62223326 |
9 | RIPK4 | 2.55972425 |
10 | TYK2 | 2.27404982 |
11 | STK10 | 2.25006089 |
12 | EPHB1 | 2.20784564 |
13 | JAK1 | 2.12743746 |
14 | TLK1 | 2.09227526 |
15 | MAP3K14 | 2.04194311 |
16 | IKBKE | 1.86701870 |
17 | LCK | 1.85927257 |
18 | TEC | 1.66904547 |
19 | GRK6 | 1.61354977 |
20 | BTK | 1.59313040 |
21 | WNK4 | 1.59002277 |
22 | ZAK | 1.56384659 |
23 | BLK | 1.53453687 |
24 | FGFR3 | 1.52435826 |
25 | ACVR1B | 1.50849878 |
26 | KIT | 1.45202421 |
27 | TESK2 | 1.42968772 |
28 | SYK | 1.42021758 |
29 | HCK | 1.39445063 |
30 | MAP4K2 | 1.36670318 |
31 | TBK1 | 1.34482268 |
32 | CLK1 | 1.31916708 |
33 | CAMKK2 | 1.29824497 |
34 | MST4 | 1.27571079 |
35 | PRKCQ | 1.21151033 |
36 | EPHA3 | 1.21112359 |
37 | NLK | 1.20848843 |
38 | CDC7 | 1.20555478 |
39 | CSK | 1.18468066 |
40 | TRIB3 | 1.15947083 |
41 | GRK1 | 1.15644370 |
42 | BMPR1B | 1.14974758 |
43 | TSSK6 | 1.14139445 |
44 | DAPK2 | 1.13019034 |
45 | NUAK1 | 1.11812363 |
46 | ERN1 | 1.09394014 |
47 | NME2 | 1.09294854 |
48 | SIK3 | 1.09207276 |
49 | PKN2 | 1.08546539 |
50 | CDK12 | 1.08050759 |
51 | MAP3K7 | 1.08025822 |
52 | LRRK2 | 1.05392231 |
53 | MAP2K6 | 1.03929778 |
54 | MAP3K10 | 1.02614871 |
55 | ALK | 1.02591155 |
56 | MAP2K3 | 1.01848767 |
57 | PINK1 | 1.00287630 |
58 | MAPK13 | 0.99507870 |
59 | IKBKB | 0.98002365 |
60 | FES | 0.97565942 |
61 | STK39 | 0.94812040 |
62 | PRKCH | 0.94680517 |
63 | SIK2 | 0.94195470 |
64 | JAK2 | 0.92605895 |
65 | ADRBK1 | 0.89519627 |
66 | CSF1R | 0.89125311 |
67 | TNK2 | 0.88744051 |
68 | CDK4 | 0.87483321 |
69 | PIM1 | 0.87307791 |
70 | PTK2B | 0.85260184 |
71 | OXSR1 | 0.84263921 |
72 | WNK3 | 0.80592708 |
73 | MATK | 0.80416248 |
74 | FGR | 0.75885980 |
75 | LYN | 0.74347315 |
76 | IRAK3 | 0.74323087 |
77 | GRK7 | 0.73585862 |
78 | KDR | 0.72439108 |
79 | PIM2 | 0.70313499 |
80 | MAP3K13 | 0.70296555 |
81 | TAOK3 | 0.69296060 |
82 | RPS6KA4 | 0.67294852 |
83 | CAMKK1 | 0.67141058 |
84 | MARK2 | 0.64494512 |
85 | CHUK | 0.63615671 |
86 | NEK2 | 0.63257367 |
87 | PASK | 0.61686043 |
88 | PRKD2 | 0.61506356 |
89 | MAP2K2 | 0.60241054 |
90 | STK11 | 0.56615347 |
91 | PIK3CG | 0.56399760 |
92 | MELK | 0.56091902 |
93 | MAP3K8 | 0.55908908 |
94 | MARK3 | 0.55383361 |
95 | INSRR | 0.53829829 |
96 | PDK1 | 0.53242610 |
97 | RPS6KA6 | 0.52745675 |
98 | PDGFRB | 0.52698294 |
99 | ROCK2 | 0.48971122 |
100 | IRAK4 | 0.48757923 |
101 | CSNK1A1L | 0.47707021 |
102 | MAPK7 | 0.47050805 |
103 | HIPK2 | 0.46449898 |
104 | PTK6 | 0.45505259 |
105 | MAPK12 | 0.43955631 |
106 | RPS6KA5 | 0.43362884 |
107 | ICK | 0.43164105 |
108 | RPS6KB2 | 0.42410798 |
109 | IRAK1 | 0.40689378 |
110 | FYN | 0.39988372 |
111 | MAPK11 | 0.37965107 |
112 | FGFR1 | 0.36643652 |
113 | MAPK15 | 0.36562694 |
114 | CDK6 | 0.36452771 |
115 | SIK1 | 0.36294387 |
116 | MAP3K3 | 0.36286032 |
117 | BCKDK | 0.35943947 |
118 | INSR | 0.34333247 |
119 | RAF1 | 0.34229248 |
120 | TTN | 0.33915859 |
121 | MAPKAPK2 | 0.33844357 |
122 | EGFR | 0.33647271 |
123 | PAK3 | 0.33376288 |
124 | PRKCZ | 0.31505960 |
125 | BRD4 | 0.30952708 |
126 | BMX | 0.30911031 |
127 | TYRO3 | 0.30359547 |
128 | STK4 | 0.30286136 |
129 | CHEK1 | 0.29981303 |
130 | CAMK1 | 0.29786643 |
131 | TRPM7 | 0.29766713 |
132 | CDK19 | 0.28765383 |
133 | CAMK4 | 0.28755596 |
134 | IGF1R | 0.28575163 |
135 | WNK1 | 0.27711561 |
136 | TAOK1 | 0.27542261 |
137 | PKN1 | 0.27395408 |
138 | MAP3K11 | 0.26118854 |
139 | DMPK | 0.25881218 |
140 | ADRBK2 | 0.25704761 |
141 | RPS6KC1 | 0.25419933 |
142 | RPS6KL1 | 0.25419933 |
143 | PRKCD | 0.25132946 |
144 | BMPR2 | 0.24143741 |
145 | DYRK2 | 0.23808265 |
146 | TGFBR1 | 0.23765062 |
147 | ABL1 | 0.23659360 |
148 | CSNK1G3 | 0.23076994 |
149 | PAK2 | 0.22892334 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.68014056 |
2 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 4.10898109 |
3 | Allograft rejection_Homo sapiens_hsa05330 | 4.08932815 |
4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.70397572 |
5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.44133861 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.97730944 |
7 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.77937932 |
8 | Measles_Homo sapiens_hsa05162 | 2.77324409 |
9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.53913603 |
10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.45808865 |
11 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.44561428 |
12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.41154551 |
13 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 2.19440390 |
14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.97857467 |
15 | Asthma_Homo sapiens_hsa05310 | 1.84631085 |
16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.76672222 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.75126008 |
18 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.71320492 |
19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69883369 |
20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.68496257 |
21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67052116 |
22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.64549799 |
23 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.44943137 |
24 | DNA replication_Homo sapiens_hsa03030 | 1.40775692 |
25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37425424 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31490684 |
27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27381462 |
28 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.25686614 |
29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.25415694 |
30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25140625 |
31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23605104 |
32 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23083836 |
33 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.21662147 |
34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.19305057 |
35 | Ribosome_Homo sapiens_hsa03010 | 1.18256099 |
36 | Phototransduction_Homo sapiens_hsa04744 | 1.16392081 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 1.13669377 |
38 | HTLV-I infection_Homo sapiens_hsa05166 | 1.10782857 |
39 | Malaria_Homo sapiens_hsa05144 | 1.07799840 |
40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.07228551 |
41 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05910653 |
42 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.04816747 |
43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02007145 |
44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.01162691 |
45 | Apoptosis_Homo sapiens_hsa04210 | 1.00931354 |
46 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00423899 |
47 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.00188795 |
48 | Shigellosis_Homo sapiens_hsa05131 | 0.99907519 |
49 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99769168 |
50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99763154 |
51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99080676 |
52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97810200 |
53 | Influenza A_Homo sapiens_hsa05164 | 0.95684026 |
54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95241523 |
55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.90699126 |
56 | Mismatch repair_Homo sapiens_hsa03430 | 0.85802684 |
57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84535803 |
58 | Spliceosome_Homo sapiens_hsa03040 | 0.83500660 |
59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82550080 |
60 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.81643996 |
61 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.80923478 |
62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80103781 |
63 | Legionellosis_Homo sapiens_hsa05134 | 0.79082266 |
64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75564997 |
65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75175046 |
66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71453907 |
67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71228691 |
68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70999857 |
69 | Base excision repair_Homo sapiens_hsa03410 | 0.70449385 |
70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.69425039 |
71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69250037 |
72 | ABC transporters_Homo sapiens_hsa02010 | 0.68407990 |
73 | Salmonella infection_Homo sapiens_hsa05132 | 0.68287455 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67943027 |
75 | Hepatitis C_Homo sapiens_hsa05160 | 0.67914412 |
76 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67147299 |
77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66872684 |
78 | Tuberculosis_Homo sapiens_hsa05152 | 0.66220254 |
79 | Morphine addiction_Homo sapiens_hsa05032 | 0.64012882 |
80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61622801 |
81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.61470488 |
82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61140035 |
83 | Platelet activation_Homo sapiens_hsa04611 | 0.59903164 |
84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58655358 |
85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56951361 |
86 | Pertussis_Homo sapiens_hsa05133 | 0.56435525 |
87 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56260231 |
88 | Endocytosis_Homo sapiens_hsa04144 | 0.55806933 |
89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.55617590 |
90 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55549117 |
91 | RNA transport_Homo sapiens_hsa03013 | 0.54170033 |
92 | Cell cycle_Homo sapiens_hsa04110 | 0.54156837 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.53321931 |
94 | Phagosome_Homo sapiens_hsa04145 | 0.53074468 |
95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.50460896 |
96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50119923 |
97 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49918865 |
98 | RNA degradation_Homo sapiens_hsa03018 | 0.49530868 |
99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49251359 |
100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49208065 |
101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48333798 |
102 | Taste transduction_Homo sapiens_hsa04742 | 0.48027760 |
103 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.47184584 |
104 | Homologous recombination_Homo sapiens_hsa03440 | 0.46579684 |
105 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.46482816 |
106 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.44258209 |
107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.43267115 |
108 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43195812 |
109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42558374 |
110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42273841 |
111 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41717116 |
112 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40727520 |
113 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.40684392 |
114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39851058 |
115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39122383 |
116 | Proteasome_Homo sapiens_hsa03050 | 0.38989215 |
117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.37702827 |
118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.37518893 |
119 | Basal transcription factors_Homo sapiens_hsa03022 | 0.37475951 |
120 | Lysosome_Homo sapiens_hsa04142 | 0.37304971 |
121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36192467 |
122 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.35679566 |
123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35357947 |
124 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.35113632 |
125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.34003740 |
126 | RNA polymerase_Homo sapiens_hsa03020 | 0.32917626 |
127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30223438 |
128 | Peroxisome_Homo sapiens_hsa04146 | 0.29434930 |
129 | Prostate cancer_Homo sapiens_hsa05215 | 0.29157709 |
130 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.29146027 |
131 | Nicotine addiction_Homo sapiens_hsa05033 | 0.28673522 |
132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.25952053 |
133 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.25312627 |
134 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.24175515 |
135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.22326668 |
136 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22120894 |
137 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.21821658 |
138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.21782642 |
139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.20843668 |
140 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.16676781 |
141 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.14131146 |
142 | Pathways in cancer_Homo sapiens_hsa05200 | 0.12572626 |
143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.11126246 |
144 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08953093 |
145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.08868861 |